<SEC-DOCUMENT>0001493152-25-007880.txt : 20250221
<SEC-HEADER>0001493152-25-007880.hdr.sgml : 20250221
<ACCEPTANCE-DATETIME>20250221163026
ACCESSION NUMBER:		0001493152-25-007880
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250217
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250221
DATE AS OF CHANGE:		20250221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		25652441

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:PRPH="http://prophaselabs.com/20250217">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_PRPH_prophaselabs.com_20250217 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250217_20250217 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000868278 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000004" name="dei:EntityCentralIndexKey">0000868278</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prph-20250217.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-17</xbrli:startDate>
        <xbrli:endDate>2025-02-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20250217__20250217_zoFZt9nIOfe3"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_904_edei--DocumentPeriodEndDate_c20250217__20250217_zCrkWaHlPkM1"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 17, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20250217__20250217_zts2WaO4lj0b"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000011" name="dei:EntityRegistrantName">PROPHASE
LABS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Company as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20250217__20250217_zswtNBfPaFVi"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20250217__20250217_zhd87vCixax6"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000013" name="dei:EntityFileNumber">000-21617</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20250217__20250217_zcQ7Ej6GTbng"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000014" name="dei:EntityTaxIdentificationNumber">23-2577138</ix:nonNumeric></span>
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20250217__20250217_z8bAAOJdWhLg"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000015" name="dei:EntityAddressAddressLine1">711
                                            Stewart Avenue</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20250217__20250217_ziUrchEDCFLl"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_905_edei--EntityAddressCityOrTown_c20250217__20250217_zAetWt7vdJB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000017" name="dei:EntityAddressCityOrTown">Garden
    City</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">, </span><span id="xdx_900_edei--EntityAddressStateOrProvince_c20250217__20250217_z9CsRMAFYqo9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New
    York</ix:nonNumeric></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20250217__20250217_zBkjep1mNQsf"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000019" name="dei:EntityAddressPostalZipCode">11530</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_909_edei--CityAreaCode_c20250217__20250217_zIDYiP2uhDy2"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000020" name="dei:CityAreaCode">(215)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20250217__20250217_zz4KYXx7Mc08"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000021" name="dei:LocalPhoneNumber">345-0919</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any
of the following provisions (<i>see</i> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--WrittenCommunications_c20250217__20250217_zQ8Di5YzX4h6"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20250217__20250217_zK9Bmh2bVJH6"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20250217__20250217_zMjEd5EtIup2"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250217__20250217_zAlyRYOZ7lM2"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registered Pursuant to Section 12(b) of the Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20250217__20250217_zIBRv4645FUl"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.0005</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250217__20250217_zQXq7I9OAuBd"><ix:nonNumeric contextRef="AsOf2025-02-17" id="Fact000027" name="dei:TradingSymbol">PRPH</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90E_edei--SecurityExchangeName_c20250217__20250217_zr5kc67bqGW"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_903_edei--EntityEmergingGrowthCompany_c20250217__20250217_zdsWwQVLLOyj"><ix:nonNumeric contextRef="AsOf2025-02-17" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 18, 2025, ProPhase Labs, Inc. (the &#8220;Company&#8221;) announced that Stuart Hollenshead has been appointed to serve as Chief
Operating Officer of the Company, effective on February 17, 2025, to replace Jed Latkin, who as previously reported, stepped down as
Chief Operating Officer effective February 14, 2025 to pursue other business opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart
Hollenshead, age 41, is a seasoned C-level executive with over 15 years of experience at the intersection of media, entertainment, e-commerce,
marketing, product and technology. Mr. Hollenshead&#8217;s expertise spans strategic business planning, P&amp;L management, direct, paid
and lifecycle marketing, data analytics, product innovation, and audience development for subscription, e-commerce, and digital platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hollenshead worked at Barstool Sports from June 2018 to March 2024, where he rose from EVP of Growth to Chief Operating Officer and Chief
Business Officer. During his tenure, Barstool experienced unprecedented expansion across audience, revenue streams, and business lines,
culminating in its $600-million acquisition by PENN Entertainment. He led teams across engineering, product development, marketing, data,
and business development, spearheading initiatives that redefined media monetization and audience engagement. Currently, Mr. Hollenshead
serves as CEO (previously CRO) of 10PM Curfew, one of the largest and fastest-growing female-centric media platforms, with an audience
of over 70 million. Under his leadership, 10PM Curfew has become a leader in creating high-impact brand partnerships and delivering exceptional
value through innovative content and audience engagement strategies. Mr. Hollenshead&#8217;s career is defined by his ability to build,
scale, monetize and operate businesses, leveraging a blend of creative vision and analytical precision to drive exceptional results.
Mr. Hollenshead received his bachelor&#8217;s degree from Bucknell University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the repositioning of the Company as a consumer products company, the Company believes that Mr. Hollenshead is well suited as Chief Operating
Officer given his extensive experience at world class marketing companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 14, 2025, Mr. Hollenshead accepted the Company&#8217;s Offer and Terms of Employment (the &#8220;Hollenshead Offer Letter&#8221;),
which provides that Mr. Hollenshead&#8217;s annual base compensation in connection with his service as Chief Operating Officer of the
Company will be $190,000. In addition, as an inducement to his employment as Chief Operating Officer of the Company, the Company granted
Mr. Hollenshead stock options (the &#8220;Options&#8221;) to purchase up to 500,000 shares of the Company&#8217;s common stock, with
an exercise price of $0.60 per share and will be exercisable for a period of seven years, pursuant to an inducement option award agreement
(the &#8220;Inducement Agreement&#8221;) to be entered into between the Company and Mr. Hollenshead. This award was made in accordance
with the employment inducement award exemption provided by Nasdaq Rule 5635(c)(4) and was therefore not awarded under the Company&#8217;s
stockholder approved equity plan. The Options will vest over a three-year period, with 25% of the Options vested at the time of grant
and the remainder of the Options vesting ratably on each of the first three anniversaries of the commencement date of his employment
and subject to continued service on each vesting date. Mr. Hollenshead will be eligible for an annual discretionary bonus based on both
the performance of the Company and of Mr. Hollenshead, individually. Mr. Hollenshead will also be eligible to participate in any and
all benefit plans of the Company that are made generally available to similarly-situated employees of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Mr. Hollenshead&#8217;s appointment as Chief Operating Officer the Company, Mr. Hollenshead will enter into the Company&#8217;s
standard form of indemnification agreement, a copy of which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K
filed with the Securities and Exchange Commission on August 19, 2009 and is incorporated herein by reference. Pursuant to the terms of
this agreement, the Company may be required, among other things, to indemnify Mr. Hollenshead for certain expenses, including attorneys&#8217;
fees, judgments, fines and settlement amounts incurred by him in any action or proceeding arising out of his service as principal accounting
officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between Mr. Hollenshead and any of the officers or directors of the Company, and there are no related party
transactions with Mr. Hollenshead that are reportable under Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
foregoing summary of the Hollenshead Offer Letter and Inducement Agreement does not purport to be a complete description and is qualified
in its entirety by reference to the full text of the Hollenshead Offer Letter and Inducement Agreement, which are included as Exhibit
10.1 and Exhibit 10.2 hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Company&#8217;s press release dated February 18, 2025, relating to the announcement described in Item 5.02, is furnished
as Exhibit 99.1 to this Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; width: 0.15in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Hollenshead Offer Letter, dated as of February 14, 2025, by and between ProPhase Labs, Inc. and Stuart Hollenshead</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Inducement Option Award Agreement, effective as of February 17, 2025, by and between ProPhase Labs, Inc. and Stuart Hollenshead</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated February 18, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Certain portions of this Exhibit have been omitted pursuant to Regulation S-K Item 601(a)(6) promulgated under the Exchange Act. The
Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ProPhase
    Labs, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 47%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Ted Karkus</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
February 21, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi7aRbrLTUkWsIkXEbbRTCbaZMol/R/KWxhZxGBiG9773hBiJJS1MgwzHeVnAHtuu0R6hxBoZ7RmDI1utFYRb4sU4z9r6/v2BGQUGA5OOZXoKQm+9G4eVglhOZDyRKSSJmqYw24joq2dka1Oh9UY3oG0FO6aODXrNryFhr59kqX31VQdkZ8gqSMbxIL9BxomELd31g/jqoCgyEY36icSS6dYFV/70aL8k5A22oc4N9H+jD/1ESnw= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><B>CERTAIN
PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES
THAT INFORMATION HAS BEEN REDACTED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><IMG SRC="ex10-1_001.jpg" ALT="" STYLE="height: 68px; width: 200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: transparent"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February
14, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stuart
Hollenshead</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Offer
and Terms of Employment</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stu:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is with great pleasure that I offer you a position with ProPhase Labs, Inc. (&ldquo;PRPH&rdquo;) as Chief Operating Officer (&ldquo;COO&rsquo;&rsquo;).
You will be reporting directly to Ted Karkus. We at ProPhase work closely together in a hands-on, team oriented, collaborative environment.
We are developing a high energy environment for the quick thinking, skilled professional that is looking to expand our consumer products
business, our genomics business, our biopharmaceuticals business, and our company as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
position will be, as with all Associates, on an &ldquo;at will&rdquo; basis. Assuming acceptance of the terms outlined below, I look
forward to your starting upon signing of this agreement. The following outlines the terms discussed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                            position will be considered a full-time position.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                            compensation will be a base salary of $190,000 per annum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will receive an incentive stock option grant to purchase 500,000 shares of ProPhase Labs
                                            common stock at $0.60 per share subject to executing our standard written stock option agreement
                                            containing the specific terms and conditions of the stock option grant (25% vested at grant
                                            date, 25% per year vesting thereafter over 3 years).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will be eligible for an annual bonus based on both company and individual performance to
                                            be paid at the discretion of the Compensation Committee of the Board of Directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will be eligible for additional stock options at the discretion of the Compensation Committee
                                            of the Board of Directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will be paid the base compensation every other Friday, 26 paychecks annually, subject to
                                            all Federal, State and Local tax, withholdings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 110pt; text-align: justify; text-indent: -48pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">711
Stewart Ave, Suite 200 &#9679; Garden City, NY 11530 &#9679; U.S.A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
516-464-6121 &#9679; Fax: 516-464-6132 &#9679; For information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.ProPhaseLabs.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will be eligible for participation in our various employee benefit plans based upon
                                            the terms of each of the individual plan provisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 102pt; text-align: justify; text-indent: 1pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You will receive 3 paid weeks&rsquo; vacation for each 12 months
employment in addition to all other scheduled holidays in accordance with Prophase&rsquo;s policy.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 102pt; text-align: justify; text-indent: 1pt; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: Transparent">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All out of pocket expenses such as but not limited to client
lunches, travel etc (approved in advance) shall be reimbursed to you in a timely fashion.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of the company, I am pleased to extend this offer to you. This offer will expire on February 21, 2025. I look forward to a long
relationship and believe you can become an important component and member of our team to achieve success. If you have any questions,
please feel free to contact me at your earliest convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
look forward to your favored reply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I> </FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 13%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer
    Accepted:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                            Stuart Hollenshead</I></FONT></P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/14/2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDUCEMENT
OPTION AWARD AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), is made effective as of the 17th day of February 2025 (hereinafter called the &ldquo;<U>Date
of Grant</U>&rdquo;), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the &ldquo;<U>Company</U>&rdquo;), and
Stuart Hollenshead (hereinafter called the &ldquo;<U>Optionee</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RECITALS</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Optionee satisfies the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) and the related guidance under Nasdaq
IM 5635-1;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the grant of this &ldquo;Option&rdquo; (as defined below) to the Optionee was approved by the Compensation Committee of the Board of
Directors of the Company (the &ldquo;<U>Committee</U>&rdquo;) and complies with the exemption from the stockholder approval requirement
for &ldquo;inducement grants&rdquo; provided under Rule 5635(c)(4) of the Nasdaq Listing Rules;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Option evidenced by this Agreement was granted to the Optionee pursuant to the inducement grant exception under Nasdaq Stock Market
Rule 5635(c)(4), and not pursuant to the Company&rsquo;s 2022 Equity Compensation Plan or any other equity incentive plan of the Company,
as an inducement that is material to the Optionee entering into employment with the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Committee has determined that it would be in the best interests of the Company and its stockholders to grant the Option provided
for herein to the Optionee pursuant to the terms set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Grant of the Option</U>. The Company hereby grants to the Optionee the right and option (the &ldquo;<U>Option</U>&rdquo;) to purchase,
on the terms and conditions hereinafter set forth, all or any part of an aggregate of 500,000 shares of common stock of the Company,
par value $0.0005 per share (the &ldquo;<U>Shares</U>&rdquo;), subject to adjustment as set forth in Section 4 below. The purchase price
of the Shares subject to the Option shall be $0.60 per Share (the &ldquo;<U>Option Price</U>&rdquo;). The Option is intended to be a
non-qualified stock option, and is not intended to be treated as an option that complies with Section 422 of the Internal Revenue Code
of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Vesting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All Options granted pursuant to this Agreement shall vest and become exercisable in accordance with the following schedule, in each case,
subject to the Optionee&rsquo;s continued &ldquo;Employment&rdquo; (as defined below) through the applicable vesting date, except as
otherwise provided in Section 2(b) below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%">Date of Grant</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">25</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">First Anniversary of the Date of Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Second Anniversary of the Date of Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Third Anniversary of the Date of Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any portion of the Option that does not become vested and exercisable in accordance with the provisions of Section 2 hereof shall be
automatically forfeited and cancelled for no value without any consideration being paid therefor and otherwise without any further action
of the Company whatsoever on the earliest to occur of the events listed in Section 3. For the avoidance of doubt, there shall be no proportionate
or partial vesting in the periods prior to each vesting date set forth in Section 2(a) and all vesting shall occur only on the applicable
vesting date, subject to the Optionee&rsquo;s continued Employment with the Company on each applicable vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Exercise of Option</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Period of Exercise</U>. Subject to the provisions of this Agreement, the Optionee may exercise all or any part of the vested portion
of the Option at any time prior to the <U>earliest</U> to occur of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the seventh anniversary of the Date of Grant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
one year following the date of the Optionee&rsquo;s termination of &ldquo;Employment&rdquo; (as defined below) due to death or &ldquo;Disability&rdquo;
(as defined below);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
thirty (30) days following the date of the Optionee&rsquo;s termination of Employment by the Company without &ldquo;Cause&rdquo; (as
defined below); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the date of the Optionee&rsquo;s termination of Employment by the Company for Cause or by the Optionee for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Employment</U>&rdquo; shall mean (i) the Optionee&rsquo;s employment if the Optionee is an employee
of the Company or any of its Affiliates, (ii) the Optionee&rsquo;s services as a consultant, advisor or other service provider, if the
Optionee is a consultant, advisor or other service provider to the Company or its Affiliates and (iii) the Optionee&rsquo;s services
as a non-employee director, if the Optionee is a non-employee member of the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Disability</U>&rdquo; shall mean the inability of the Optionee to perform in all material respects
his or her duties and responsibilities to the Company or any Affiliate, by reason of a physical or mental disability or infirmity which
inability is reasonably expected to be permanent and has continued (i) for a period of six consecutive months or (ii) such shorter period
as the Committee may reasonably determine in good faith. The Disability determination shall be in the sole discretion of the Committee
and the Optionee (or his or her representative) shall furnish the Committee with medical evidence documenting the Optionee&rsquo;s disability
or infirmity which is satisfactory to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Cause</U>&rdquo; shall mean &ldquo;Cause&rdquo; as defined in any employment agreement then in
effect between the Optionee and the Company or any entity directly or indirectly controlling, controlled by or under common control with
the Company or any other entity designated by the Board in which the Company or an affiliate has an interest (each such entity, an &ldquo;<U>Affiliate</U>&rdquo;)
or if not defined therein or, if there shall be no such agreement, (i) the willful failure or refusal by such Optionee to perform his
or her duties to the Company or its Affiliates (other than any such failure resulting from such Optionee&rsquo;s incapacity due to physical
or mental illness), which has not ceased within ten days after a written demand for substantial performance is delivered to such Optionee
by the Company, which demand identifies the manner in which the Company believes that such Optionee has not performed such duties; (ii)
the willful engaging by such Optionee in misconduct which is materially injurious to the Company or its Affiliates, monetarily or otherwise
(including breach of any confidentiality or non-competition covenants to which such Optionee is bound); (iii) the conviction of such
Optionee of, or the entering of a plea of nolo contendere by such Optionee with respect to, a felony or to any crime which is materially
injurious to the Company or its Affiliates; or (iv) substantial or repeated acts of dishonesty by such Optionee in the performance of
his/her duties to the Company or its Affiliates. The determination of the existence of Cause shall be made by the Committee in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Method of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Subject to Section 3(a), the vested portion of the Option may be exercised by delivering to the Company at its principal office written
notice of intent to so exercise; <U>provided</U> that, the Option may be exercised with respect to whole Shares only. Such notice shall
specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the purchase price
per Share of the Option (the &ldquo;<U>Option Price</U>&rdquo;). The payment of the Option Price may be made at the election of the Optionee
(i) in cash or its equivalent (e.g., by check), (ii) to the extent permitted by the Committee, in Shares having a &ldquo;Fair Market
Value&rdquo; (as defined below) equal to the aggregate Option Price for the Shares being purchased and satisfying such other requirements
as may be imposed by the Committee; provided, that such Shares have been held by the Optionee for no less than six months (or such other
period as established from time to time by the Committee in order to avoid adverse accounting treatment applying generally accepted accounting
principles), (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares, (iv) if there is a public market
for the Shares at such time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of
the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate Option Price for
the Shares being purchased, or (v) through a &ldquo;net settlement.&rdquo; In the case of a &ldquo;net settlement&rdquo; of the Option,
the Company will not require a cash payment of the Option Price of the Option, but will reduce the number of Shares issued upon the exercise
by the largest number of whole Shares that have a Fair Market Value that does not exceed the aggregate Option Price. With respect to
any remaining balance of the aggregate Option Price, the Company shall accept a cash payment. The Optionee shall have no rights to dividends
or other rights of a stockholder with respect to Shares subject to the Option until the Optionee has given written notice of exercise
of the Option, paid in full for such Shares as applicable and, if applicable, has satisfied any other conditions set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Notwithstanding any other provision of this Agreement to the contrary, the Option may not be exercised prior to the completion of any
registration or qualification of the Option or the Shares under applicable state and federal securities or other laws, or under any ruling
or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be
necessary or advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
In the event of the Optionee&rsquo;s death, the vested portion of the Option shall remain exercisable by the Optionee&rsquo;s executor
or administrator, or the person or persons to whom the Optionee&rsquo;s rights under this Agreement shall pass by will or by the laws
of descent and distribution as the case may be, to the extent set forth in Section 3(a). Any heir or legatee of the Optionee shall take
rights herein granted subject to the terms and conditions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.55in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;<U>Fair Market Value</U>&rdquo; shall mean on a given date, (i) if there should be a public market
for the Shares on such date, the closing price of the Shares as reported on such date on the composite tape of the principal national
securities exchange on which such Shares are listed or admitted to trading or, if no composite tape exists for such national securities
exchange on such date, then the closing price on the principal national securities exchange on which such Shares are listed or admitted
to trading, (ii) if the Shares are not listed or admitted on a national securities exchange, the arithmetic mean of the per Share closing
bid price and per Share closing asked price on such date as quoted on the National Association of Securities Dealers Automated Quotation
System (or such other market in which such prices for the Shares are regularly quoted) or (iii) if there is no market on which the Shares
are regularly quoted, the Fair Market Value shall be the value established by the Committee in good faith; provided, however that in
determining the Fair Market value, the Committee shall not apply a discount for any minority interest. With respect to (i) and (ii) above,
if no sale of Shares shall have been reported on such composite tape or such national securities exchange on such date or quoted on the
National Association of Securities Dealer Automated Quotation System or other applicable market on such date, then the immediately preceding
date on which sales of the Shares have been so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Adjustments Upon Certain Events</U>. Notwithstanding any other provisions of this Agreement to the contrary, the following provisions
shall apply to the Option granted under this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Generally</U>. In the event of any change in the outstanding Shares after the Date of Grant by reason of any Share dividend or split,
reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of Shares or other corporate exchange or change
in capital structure, any distribution or special dividend to stockholders of Shares, cash or other property (other than regular cash
dividends), or any similar event, the Committee without liability to any person shall make such substitution or adjustment, if any, as
it deems to be equitable (subject to Section 12 below), as to the number or kind of Shares or other securities subject to this Option
and the per share exercise price thereof; provided that the Committee shall determine in its sole discretion the manner in which such
substitution or adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Change of Control</U>. In the event of a &ldquo;Change of Control&rdquo; (or similar corporate transaction) after the Date of Grant,
the Committee may accelerate, vest or cause the restrictions to lapse with respect to all or any portion of this Option. With respect
to any portion of this Option that becomes vested pursuant to the preceding sentence, the Committee may (A) cancel such portion for fair
value (as determined in the sole discretion of the Committee) which may equal the excess, if any, of value of the consideration to be
paid in the Change of Control transaction to holders of the same number of Shares subject to awards (or, if no consideration is paid
in any such transaction, the Fair Market Value of the Shares) over the aggregate exercise price of the Option, (B) provide for the issuance
of substitute awards that will substantially preserve the otherwise applicable terms of this Option previously granted hereunder as determined
by the Committee in its sole discretion or (C) provide that for a period of at least 10 days prior to the Change of Control, the vested
portion of this Option, as may be accelerated pursuant to the first sentence of this subsection (b), shall be exercisable as to all Shares
subject hereto and that upon the occurrence of the Change of Control, this Option shall terminate and be of no further force or effect.
For the avoidance of doubt, pursuant to (A) above, the Committee may cancel this Option for no consideration if the aggregate Fair Market
Value of the Shares subject to this Option is less than or equal to the aggregate Option Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, &ldquo;Change of Control&rdquo; shall mean the occurrence of any one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (for
purposes of SEC Rule 13d) (&ldquo;<U>Person</U>&rdquo;), acquires ownership of the Shares that, together with the Shares held by such
Person, constitutes more than 50% of the total voting power of the Shares of the Company. No Change of Control shall have occurred in
the event Ted Karkus (the &ldquo;<U>Executive</U>&rdquo;) or a group which includes Executive acquires more than 50% of the voting control
of the Company. The acquisition of additional Shares by any one Person, who is considered to own more than 50% of the total voting power
of the Shares of the Company will not be considered an additional Change of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12-month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 27.35pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; shall mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing,
a transaction will not be deemed a Change of Control unless the transaction qualifies as a change of control event within the meaning
of Section 409A. Further and for the avoidance of doubt, a transaction will not constitute a Change of Control if its primary purpose
is to: (1) change the state of the Company&rsquo;s incorporation, or (2) create a holding company that will be owned in substantially
the same proportions by the persons who held the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Option Recovery</U>. If the Committee determines that the Optionee (a) engaged in conduct that constituted Cause as defined in Section
3(a) of this Agreement at any prior to the Optionee&rsquo;s termination of services, (b) engaged in conduct during the 6 month period
after the Optionee&rsquo;s termination of services that would have constituted Cause if the Optionee had not ceased to provide services,
or (c) violates the terms of any non-compete agreement, non-solicitation agreement, confidentiality agreement, or any other restriction
on the Optionee&rsquo;s post-termination activities established under any agreement with the Company or other Company policy or arrangement
during the 6 months after the Optionee&rsquo;s ceases to provide services to the Company, then (i) any Option held by the Optionee shall
immediately terminate, and the Optionee shall automatically forfeit all Shares underlying any exercised portion of an Option for which
the Company has not yet delivered the Share certificates, upon refund by the Company of the Option Price paid by the Optionee for such
Shares and (ii) the Optionee shall return any Shares received upon exercise of this Option or repay to the Company any proceeds received
from the sale of other disposition of the Shares transferred pursuant to this Option less the Option Price. Upon any exercise of an Option,
the Company may withhold delivery of share certificates pending resolution of an inquiry that could lead to a finding resulting in a
forfeiture under this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>No Right to Continued Employment</U>. The granting of the Option evidenced hereby and this Agreement shall impose no obligation on
the Company or any Affiliate to continue the Employment of the Optionee and shall not lessen or affect the Company&rsquo;s or its Affiliate&rsquo;s
right to terminate the Employment of such Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Transferability</U>. The Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by
the Optionee otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge,
attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate; provided that the designation
of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. No such permitted
transfer of the Option to heirs or legatees of the Optionee shall be effective to bind the Company unless the Committee shall have been
furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the
transfer and the acceptance by the transferee or transferees of the terms and conditions hereof. During the Optionee&rsquo;s lifetime,
the Option is exercisable only by the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Withholding</U>. The Optionee may be required to pay to the Company or any Affiliate and the Company shall have the right and is hereby
authorized to withhold, any applicable withholding taxes in respect of the Option, its exercise or any payment or transfer under or with
respect to the Option and to take such other action as may be necessary in the opinion of the Committee to satisfy all obligations for
the payment of such withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Securities Laws</U>. Upon the acquisition of any Shares pursuant to the exercise of the Option, the Optionee will make or enter into
such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities
laws or with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Notices</U>. Any notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal
executive office of the Company and to the Optionee at the address appearing in the personnel records of the Company for the Optionee
or to either party at such other address as either party hereto may hereafter designate in writing to the other. Any such notice shall
be deemed effective upon receipt thereof by the addressee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Choice of Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without
regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Section 409A</U>. The Company intends that income realized by the Optionee pursuant to this Agreement will not be subject to taxation
under Section 409A of the Code. The provisions of this Agreement shall be interpreted and construed in favor of satisfying any applicable
requirements of Section 409A of the Code. In the event that it is reasonably determined by the Committee that, as a result of Section
409A of the Code, any payment or delivery of Shares in respect of the Option may not be made at the time contemplated by the terms of
this Agreement, as the case may be, without causing Optionee to be subject to taxation under Section 409A of the Code, the Company shall
use reasonably commercial efforts to make such payment or delivery of Shares on the first day that would not result in the Optionee incurring
any tax liability under Section 409A of the Code. If Optionee is a &ldquo;specified employee&rdquo; (within the meaning of Section 409A(a)(2)(B)(i)
of the Code), any payment and/or delivery of Shares in respect of the Option that are linked to the date of the Optionee&rsquo;s separation
from service shall not be made prior to the date which is six (6) months after the date of such Optionee&rsquo;s separation from service
from the Company, determined in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company, in
its reasonable discretion, may amend (including retroactively) this Agreement in order to conform to the applicable requirements of Section
409A of the Code, including amendments to facilitate the Optionee&rsquo;s ability to avoid taxation under Section 409A of the Code. However,
the preceding provisions shall not be construed as a guarantee by the Company of any particular tax result for income realized by the
Optionee pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Administration</U>. This Agreement shall be administered by the Committee. The Committee is authorized to interpret this Agreement,
to establish, amend and rescind any rules and regulations relating to this Agreement, and to make any other determinations that it deems
necessary or advisable for the administration of this Agreement. The Committee may correct any defect or supply any omission or reconcile
any inconsistency in this Agreement in the manner and to the extent the Committee deems necessary or advisable. Any decision of the Committee
in the interpretation and administration of this Agreement, as described herein, shall lie within its sole and absolute discretion and
shall be final, conclusive and binding on all parties concerned (including, but not limited to, the Optionee and his or her beneficiaries
or successors). The Committee shall have the full power and authority to establish the terms and conditions of this Option consistent
with the provisions of this Agreement and to waive any such terms and conditions at any time (including, without limitation, accelerating
or waiving any vesting conditions). Awards may, in the discretion of the Committee, be granted in assumption of, or in substitution for,
any outstanding portion of this Option. The Committee shall require payment of any minimum amount it may determine to be necessary to
withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of this Option. Unless the Committee
specifies otherwise, the Optionee may elect to pay a portion or all of such minimum withholding taxes by (a) delivery in Shares or (b)
having Shares withheld by the Company from any Shares that would have otherwise been received by the Optionee. The number of Shares so
delivered or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable minimum withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Successors and Assigns</U>. This Agreement shall be binding on all successors and assigns of the Company and the Optionee, including,
without limitation, the estate of the Optionee and the executor, administrator or trustee of such estate, and any receiver or trustee
in bankruptcy or any other representative of the Optionee&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Signature in Counterparts</U>. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signatures
on next page.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PROPHASE
    LABS, INC</B>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OPTIONEE</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stuart Hollenshead</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart
    Hollenshead</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page to Inducement Option Award Agreement]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GARDEN
CITY, NY, February 18, 2025 (GLOBE NEWSWIRE) &ndash; ProPhase Labs, Inc. (NASDAQ: PRPH) (&ldquo;ProPhase&rdquo; or the &ldquo;Company&rdquo;),
a next-generation biotech, genomics, and consumer products company, today announced the appointment of Stu Hollenshead as Chief Operating
Officer, marking a pivotal step in the company&rsquo;s expansion into consumer-centered health and wellness products. As COO, Hollenshead
will focus on accelerating ProPhase Labs&rsquo; consumer-facing strategy, leveraging his deep expertise in direct-to-consumer growth,
subscription models, digital marketing, and audience monetization to position the company as a leader in science-backed health solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to provide additional updates very shortly regarding progress in its accounts receivables that the Company believes will
be significant, the exploration of new strategic alternatives for Nebula Genomics and DNA Complete, and additional cost-cutting measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEO
Commentary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Stu
is a world-class operator who understands how to build and scale consumer-first businesses,&rdquo; said Ted Karkus, CEO of ProPhase Labs.
&ldquo;The Company&rsquo;s particular focus going forward will be direct-to-consumer revenue streams. Furthermore, we are optimistic
about the potential for a significant inflow of capital into the Company between Q2 and Q3 2025 related to our enhanced accounts receivable
collection initiatives and look forward to updating shareholders further in the near future. These are just some of the reasons that
someone of Stu&rsquo;s caliber was willing to transition from being a consultant at ProPhase to its COO. Stu&rsquo;s relentless work
ethic, competitive will to win as well as his expertise in audience building &amp; engagement, marketing, e-commerce, and media-driven
brand growth aligns perfectly with our vision as we launch Legendz XL and Legendz Triple Edge online and prepare for the introduction
of Equivir in the near future. Stu will also be able to leverage his role at 10PM Curfew to create abundant win-win scenarios while scaling
our new product introductions to the marketplace.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Karkus continued, &ldquo;10PM Curfew represents a true competitive advantage for ProPhase. It is a one-stop shop for anyone that wants
to build their brand with the support of a highly-engaged audience of 70-million women. 10PM can guarantee tens to hundreds of millions
of impressions in the blink of an eye at the most competitive CPMs in the market while bringing a best-of-breed content shop &amp; social
platform, creator &amp; influencer management infrastructure and TikTok Shop services division to the table for immediate use. ProPhase
stood on the sidelines for years watching brands use Barstool to scale their growth. Now, ProPhase will be directly aligned with the
Barstool equivalent in the female space with 10PM. ProPhase is getting in on the ground floor while Stu continues to scale the 10PM business
exactly like he did at Barstool.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the successful sale of Pharmaloz Manufacturing, COO Jed Latkin has resigned and transitioned to a consulting role to focus on advancing
ProPhase&rsquo;s BE-Smart esophageal cancer test. He will collaborate with Igor Ban, Director of Research, for commercialization efforts.
Several discussions with potential partners are ongoing. In parallel, the next batch of BE-Smart samples is being prepared in collaboration
with The Mayo Clinic to continue to further validate the statistical evidence of the advantages and effectiveness of this breakthrough
diagnostic cancer test. The Company has determined that the target market for this potential lifesaving cancer diagnostic test is $7
- $14 billion, in the U.S. alone, and has minimal competition at present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Stu Hollenshead</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hollenshead
has played a pivotal role in two of the most high-profile media acquisitions in recent years. At Business Insider, he helped lead audience
and subscription growth, contributing to its $442-million acquisition by Axel Springer in 2015. Later, at Barstool Sports, Hollenshead
served as Chief Operating Officer &amp; Chief Business Officer, leading the company through record-breaking expansion in revenue, audience,
and product monetization&mdash;culminating in its $551-million acquisition by Penn Entertainment in 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
Barstool Sports, Hollenshead played a significant role in the company&rsquo;s evolution from a disruptive digital brand into a powerhouse
in media, commerce, and sports betting. He helped to oversee a multi-pronged business strategy, spanning subscription models, e-commerce,
direct-to-consumer monetization, licensing and branded partnerships, all while managing teams across engineering, product, marketing,
and business development. During his tenure the company experienced double-digit audience and revenue growth year over year, significantly
expanding Barstool&rsquo;s digital footprint, revenue, and brand equity&mdash;making it one of the most sought-after acquisitions in
digital media in the past decade.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to Barstool, Hollenshead built a reputation as a growth architect, scaling TheStreet&rsquo;s direct-to-consumer subscription business
to $30 million, pioneering AI-driven content automation, and later helping Business Insider surpass 100 million monthly users with a
profitable mix of B2B and direct-to-consumer subscription revenue streams. He also drove product monetization and platform migrations
at WWE, helping WWE Network reach nearly 2 million paying subscribers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to his new role at ProPhase Labs, Hollenshead will continue serving as CEO of 10PM Curfew, one of the largest and fastest-growing
female-centric digital platforms, reaching over 70 million women. Under his leadership, 10PM Curfew has built a one-of-a-kind innovative
audience and content strategy, successfully partnering with brands to drive highly engaged, scalable digital communities that create
significant brand awareness, consideration and conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stu
Hollenshead Commentary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
couldn&rsquo;t be more excited to join ProPhase Labs at this stage of its evolution,&rdquo; said Hollenshead. &ldquo;Ted Karkus built
up and sold the Cold-EEZE consumer brand for $50 million, and Jason Karkus built a multi-hundred-million-dollar Covid testing business
from scratch. With significant cash flow anticipated into ProPhase later this year, this is the perfect time and perfect fit for me to
join them in building a world-class consumer products company. The Company is currently selling its Legendz testosterone and energy boosting
products in stores, but the larger opportunity will be to sell online. I am also looking forward to leveraging our marketing platform
with the launch of Equivir, a product with enormous potential, in stores and online in the near future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
parallel, I am looking forward to numerous potential joint venture opportunities, now and in the future, to develop other company&rsquo;s
brands that have significant potential but need our marketing platform and expertise, network of influencers, etc. The opportunity is
enormous. I am excited to leverage my experience in scaling high-growth businesses to accelerate the success of Legendz, Equivir, and
leveraging my network to expand the portfolio of innovative health solutions over time.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
Hollenshead&rsquo;s leadership, ProPhase Labs is poised for rapid growth, developing innovative consumer-first health solutions and establishing
itself as a dominant player in the evolving wellness landscape.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to provide additional updates very shortly regarding the exploration of new strategic alternatives for Nebula, progress
in its accounts receivables that should be significant, and additional cost cutting measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inducement
Award</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hollenshead&nbsp;was awarded a stock option to purchase up to 500,000 shares of ProPhase common stock as an inducement to his employment
as Chief Operating Officer of&nbsp;ProPhase Labs. This award was made in accordance with the employment inducement award exemption provided
by Nasdaq Rule 5635(c)(4) and was therefore not awarded under the Company&rsquo;s stockholder approved equity plan. The option award
will vest as follows, contingent upon continued service: 25% will vest on the date of grant and 25% will vest on each of the next three
anniversaries of the grant date. The options will have a strike price of $0.60 per share and will be exercisable for a period of seven
years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ProPhase Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs Inc. (Nasdaq: PRPH) (&ldquo;ProPhase&rdquo;) is a next-generation biotech, genomics and consumer products company. Our goal is to
create a healthier world with bold action and the power of insight. We&rsquo;re revolutionizing healthcare with industry-leading Whole
Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes
a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics
with novel mechanisms of action. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their
best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs&rsquo;
valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the historical information contained herein, this document contains forward looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements regarding our strategy, plans, objectives and initiatives, including our
expectations regarding the future revenue growth potential of each of our subsidiaries, our expectations regarding future liquidity events,
the success of our efforts to collect accounts receivables and anticipated timeline for any payments relating thereto, and our ability
to successfully transition into a consumer products company. Management believes that these forward-looking statements are reasonable
as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may
cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include
but are not limited to our ability to obtain and maintain necessary regulatory approvals, general economic conditions, consumer demand
for our products and services, challenges relating to entering into and growing new business lines, the competitive environment, and
the risk factors listed from time to time in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and any other SEC filings.
The Company undertakes no obligation to update forward-looking statements except as required by applicable securities laws. Readers are
cautioned that forward-looking statements are not guarantees of future performance and are cautioned not to place undue reliance on any
forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Relations and Institutional Investor Contact:</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs, Inc.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">267-880-1111</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>investorrelations@prophaselabs.com</U></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Retail
Investor Relations Contact:</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renmark
Financial Communications</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
Boidman</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212-812-7680</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jboidman@renmarkfinancial.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex10-1_001.jpg
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "7 ;X# 2(  A$! Q$!_\0
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M);V9N=C[5_V17?A5SUK]CS,7[E&W<@'"@%LMQC![4N0W &#U [FD/EJ[8!7
MX-,*L9TZ$YSFO99XR+NA:C_96O07*.P5FVNIZ8KVU6$D:NIR&&0:\!GSY3E3
MGGAO3Z5['X0O_P"T/#=M)NRRKM/X5XV.IV:D>W@*ETXFYSG %5+NQ@OF7S1G
M:, 5,[*  [C/L:CDO((AEG7\Z\:=2%K,]4;9Z?;V&1"",]JM]1FLXZO9H</<
M)D>]5F\2V*DJ9/FZ8 K)8BG'2X6-G&1Q^M*!@?\ UZY[_A*K;!QZ<>M,/BV
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M">0#B@"B\4]ROWRB=.#S4D&GV\.&"[F'=JM8ZX[T=.3UJ.1#N)D8Z>U!..O
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;2>_I112 4'M0>W&<T44  [D]:7 (Z444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I )\# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@!A
M%*..**Q[?7K:XUZXTM2/,B0,#GJ>X_#C]?2G%.5[+8B4XQ:3>YL5@WMW>?\
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J9P ,G''-12^'()8?L[S7$MKNR+=W&T>G.-V!V&:W**/:2N+V,+6L?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>prph-20250217.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGMObP9z5Z8WekhvWBzbek6/yos2HfM6iN4QZKmIZkN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:PRPH="http://prophaselabs.com/20250217" elementFormDefault="qualified" targetNamespace="http://prophaselabs.com/20250217">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://prophaselabs.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20250217_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20250217_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>prph-20250217_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>prph-20250217_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://prophaselabs.com/role/Cover" xlink:href="prph-20250217.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://prophaselabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45537260769808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 17,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROPHASE
LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000868278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-2577138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">711
                                            Stewart Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Garden
    City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-0919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,R#55H'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #,@U5:J@U6J.T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TW10^CVLN))07!!\1:2V=U@TX1DI-VW-XV[740?P&-F_GSS
M#4RG@]0^XG/T 2-93#>S&\8D==BP(U&0 $D?T:E4Y\28FWL?G:+\C <(2G^H
M X+@_ X<DC**%"S *JQ$UG=&2QU1D8]GO-$K/GS&H<",!AS0X4@)FKH!UB\3
MPVD>.K@"%AAA=.F[@&8EENJ?V-(!=D[.R:ZI:9KJJ2VYO$,#;T^/+V7=RHZ)
MU*@Q_TI6TBG@AETFO[;;^]T#ZP47MQ47E6AVHI$MET*\+ZX__*["SAN[M__8
M^"+8=_#K+OHO4$L#!!0    ( ,R#55J97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ S(-56F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( ,R#55JJ#5:H[0   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,R#55J97)PC$ 8
M )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ S(-56DNJD7-G!   2Q$  !@              ("!# @  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,R#55J?H!OPL0(
M .(,   -              "  :D,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>prph-20250217.xsd</File>
    <File>prph-20250217_lab.xml</File>
    <File>prph-20250217_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "PRPH",
   "nsuri": "http://prophaselabs.com/20250217",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "prph-20250217.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prph-20250217_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prph-20250217_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://prophaselabs.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-25-007880-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-007880-xbrl.zip
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M^.;55$J[>S+F ,)K'*UDH-5M[M]_W7_SZVQWOY7 !2*Z>ET"2_S=USO.:,D
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MTG\]?!C]G.HL>1Z=J@M@VV?ZSSGZ>.'%Z.%# _[#XW^:9?".'C)6/(^>S6I
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MA"+(?>0[JPB-1?$IM:J*+Y<?M:Y8\@T4+S#3^[W9O)P5E>Y4=%W&@<,)+^]
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M(YA<:##1R!""Y_2,%6[S JR':1S6SG@ B(#Y1&0W,0(!C(<W0 [WM@?!(5L
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MI<6LY2XI-_=%;_LVSH%NYD^:32KEEE(R0PP_]*7(O<,M#QY''Q:4'LTR@ 6
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M%OW=USC!UXOG-]S(]:KE9VSTR=?9*5@2CZI'O$'7Z!MMB+N*O_<(9[_\\9V
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MOIGGT>MWA_]"#OGHS?FO;U_]/U!+ P04    " #,@U5:7R*JPU$6   X8
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M^84&P\Q&@4"\ X&GGDL,-LZHTG21*RJ8YW*!F*34LVXZPDJD8S+X5WI=J.<
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M('/C@0Z& U.?ZZP+<)^B; ]O-BX1&]&4_/AP:VNTM;7ECYU4&^=Z&'TL\M
MVV2V/(I C J;):!B[87B ZG[8N;'MGEH"'Z&#6.58RA+F#(Y\)$P7<_:O*[
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M@_X@@D;0'/K=GHO&.@)M, H6 KU!.4-*I_%Z$#;DDW8MV_(GN*BZ@66;V8P
M?Q2D6T\SD]VZ<J6Q2'X0!U#!<2KC:Y2 UXG%>GH@@&IU)E,1K9$?(1J6EGH
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MG2?B=K$7/*R&K9 TE.&A8K/7!TP1@V20CQ/K$E=U0\/Z*IE1[NX58(NMPRO
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M4$L! A0#%     @ S(-56E\BJL-1%@  .&    H              ( !LS(
M &5X.3DM,2YH=&U02P$"% ,4    " #,@U5:']UYR#P<  !9R@  "P
M        @ $L20  9F]R;3@M:RYH=&U02P$"% ,4    " #,@U5:_3EUI2X#
M  #O"P  $0              @ &190  <')P:"TR,#(U,#(Q-RYX<V102P$"
M% ,4    " #,@U5:(<O)9OX*  " A@  %0              @ 'N:   <')P
M:"TR,#(U,#(Q-U]L86(N>&UL4$L! A0#%     @ S(-56@?K\[;?!P  ^%X
M !4              ( !'W0  '!R<&@M,C R-3 R,3=?<')E+GAM;%!+!08
1    !P ' *8!   Q?      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prph-20250217.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2025-02-17</startDate>
            <endDate>2025-02-17</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-17" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-17" id="Fact000004">0000868278</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-02-17" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-17" id="Fact000010">2025-02-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-17" id="Fact000011">PROPHASE LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-17" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-17" id="Fact000013">000-21617</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-17" id="Fact000014">23-2577138</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-17" id="Fact000015">711                                             Stewart Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-02-17" id="Fact000016">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-17" id="Fact000017">Garden     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-17" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-17" id="Fact000019">11530</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-17" id="Fact000020">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-17" id="Fact000021">345-0919</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-17" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-17" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-17" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-17" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-02-17" id="Fact000026">Common     Stock, par value $0.0005</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-02-17" id="Fact000027">PRPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-02-17" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-17" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
